Search research articles
Contact Us
Filters
Showing results (71-80 of 128) with videos related to
Page
of 13
Sort By:
International Journal of Cancer
|
September 22, 2006
Mutational analysis of the HER2 gene in lung tumors from Caucasian patients: mutations are mainly present in adenocarcinomas with bronchioloalveolar features
Fiamma Buttitta, Fabio Barassi, Giuseppina Fresu, et al.
Tumori
|
July 3, 2019
Treatment of metastatic non-small cell lung cancer: 2018 guidelines of the Italian Association of Medical Oncology (AIOM)
Francesco Facchinetti, Sara Pilotto, Giulio Metro, et al.
Pathologica
|
October 8, 2024
A preliminary study on the diagnostic performance of the uPath PD-L1 (SP263) artificial intelligence (AI) algorithm in patients with NSCLC treated with PD-1/PD-L1 checkpoint blockade
Alessio Cortellini, Claudia Zampacorta, Michele De Tursi, et al.
Breast Cancer Research and Treatment
|
October 24, 2009
High-risk human papilloma virus infection, tumor pathophenotypes, and BRCA1/2 and TP53 status in juvenile breast cancer
Gitana Maria Aceto, Angela Rosaria Solano, Maria Isabel Neuman, et al.
Cancer Research
|
November 4, 2005
Identification of an aberrantly spliced form of HDMX in human tumors: a new mechanism for HDM2 stabilization
Simona Giglio, Francesca Mancini, Francesca Gentiletti, et al.
Cancers
|
July 9, 2020
Digital Pathology and PD-L1 Testing in Non Small Cell Lung Cancer: A Workshop Record
Fabio Pagni, Umberto Malapelle, Claudio Doglioni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 19, 2017
Multicenter Comparison of 22C3 PharmDx (Agilent) and SP263 (Ventana) Assays to Test PD-L1 Expression for NSCLC Patients to Be Treated with Immune Checkpoint Inhibitors
Antonio Marchetti, Massimo Barberis, Renato Franco, et al.
Oncotargets and Therapy
|
April 17, 2019
Weekly alternate intensive regimen FIrB/FOx in metastatic colorectal cancer patients: an update from clinical practice
Alessio Cortellini, Katia Cannita, Alessandro Parisi, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 1, 2022
Usage of epidermal growth factor mutation testing and impact on treatment patterns in non-small cell lung cancer: An international observational study
Janakiraman Subramanian, Natasha B Leighl, Yoon-La Choi, et al.
Plos Medicine
|
April 26, 2007
Polymorphisms, mutations, and amplification of the EGFR gene in non-small cell lung cancers
Masaharu Nomura, Hisayuki Shigematsu, Lin Li, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 128) with videos related to
Sort By:
Page
of 13
International Journal of Cancer
|
September 22, 2006
Mutational analysis of the HER2 gene in lung tumors from Caucasian patients: mutations are mainly present in adenocarcinomas with bronchioloalveolar features
Fiamma Buttitta, Fabio Barassi, Giuseppina Fresu, et al.
Tumori
|
July 3, 2019
Treatment of metastatic non-small cell lung cancer: 2018 guidelines of the Italian Association of Medical Oncology (AIOM)
Francesco Facchinetti, Sara Pilotto, Giulio Metro, et al.
Pathologica
|
October 8, 2024
A preliminary study on the diagnostic performance of the uPath PD-L1 (SP263) artificial intelligence (AI) algorithm in patients with NSCLC treated with PD-1/PD-L1 checkpoint blockade
Alessio Cortellini, Claudia Zampacorta, Michele De Tursi, et al.
Breast Cancer Research and Treatment
|
October 24, 2009
High-risk human papilloma virus infection, tumor pathophenotypes, and BRCA1/2 and TP53 status in juvenile breast cancer
Gitana Maria Aceto, Angela Rosaria Solano, Maria Isabel Neuman, et al.
Cancer Research
|
November 4, 2005
Identification of an aberrantly spliced form of HDMX in human tumors: a new mechanism for HDM2 stabilization
Simona Giglio, Francesca Mancini, Francesca Gentiletti, et al.
Cancers
|
July 9, 2020
Digital Pathology and PD-L1 Testing in Non Small Cell Lung Cancer: A Workshop Record
Fabio Pagni, Umberto Malapelle, Claudio Doglioni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 19, 2017
Multicenter Comparison of 22C3 PharmDx (Agilent) and SP263 (Ventana) Assays to Test PD-L1 Expression for NSCLC Patients to Be Treated with Immune Checkpoint Inhibitors
Antonio Marchetti, Massimo Barberis, Renato Franco, et al.
Oncotargets and Therapy
|
April 17, 2019
Weekly alternate intensive regimen FIrB/FOx in metastatic colorectal cancer patients: an update from clinical practice
Alessio Cortellini, Katia Cannita, Alessandro Parisi, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 1, 2022
Usage of epidermal growth factor mutation testing and impact on treatment patterns in non-small cell lung cancer: An international observational study
Janakiraman Subramanian, Natasha B Leighl, Yoon-La Choi, et al.
Plos Medicine
|
April 26, 2007
Polymorphisms, mutations, and amplification of the EGFR gene in non-small cell lung cancers
Masaharu Nomura, Hisayuki Shigematsu, Lin Li, et al.
Page
of 13